tm
Seeing Is Believing
tm
Seeing Is Believing
Neurobo Pharmaceuticals's activity chart (see below) currently has 17 price targets and 14 ratings on display.
Analysts average stock forecasts to be materialized ratio is 50.93% with an average time for these price targets to be met of 101.11 days.
Most recent stock forecast was given by from LADENBURG on 13-Dec-2022. First documented stock forecast 30-Aug-2016.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 13-Dec-2022
$6
$4.11 (217.46%)
$6
3 years 10 months 7 days ago
(13-Dec-2022)
2/2 (100%)
$-7.2 (-54.55%)
18
Buy Since 15-Jun-2020
$3840
$3838.11 (203074.59%)
$4800
5 years 8 months 20 days ago
(31-Jan-2021)
0/2 (0%)
$2556 (199.07%)
Buy Since 30-Aug-2016
$12000.01
$11998.12 (634821.19%)
$108000.01
8 years 2 months 8 days ago
(13-Aug-2018)
3/4 (75%)
$2040.01 (20.48%)
205
Hold Since 10-Aug-2018
$12000
$11998.11 (634820.62%)
8 years 2 months 11 days ago
(10-Aug-2018)
1/1 (100%)
$1200 (11.11%)
27
$12000
$11998.11 (634820.62%)
8 years 2 months 12 days ago
(09-Aug-2018)
1/2 (50%)
$-7620 (-38.84%)
1
What is NRBO (Neurobo Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on NRBO (Neurobo Pharmaceuticals)?
Which analyst has the current lower performing score on NRBO (Neurobo Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on NRBO (Neurobo Pharmaceuticals)?
Which analyst is the currently most bullish on NRBO (Neurobo Pharmaceuticals)?
Which analyst is the currently most reserved on NRBO (Neurobo Pharmaceuticals)?
